{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T05:03:29Z","timestamp":1777439009627,"version":"3.51.4"},"reference-count":13,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2024,1,1]]},"DOI":"10.1001\/jamadermatol.2023.4577","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T16:32:47Z","timestamp":1701275567000},"page":"19","source":"Crossref","is-referenced-by-count":6,"title":["Isotretinoin and Adverse Psychiatric Effects"],"prefix":"10.1001","volume":"160","author":[{"given":"Parker","family":"Magin","sequence":"first","affiliation":[{"name":"School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaun","family":"Prentice","sequence":"additional","affiliation":[{"name":"School of Psychology, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"2","key":"ded230020r1","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1111\/bjd.v184.2","article-title":"Reviewing the global burden of acne: how could we improve care to reduce the burden?","volume":"184","author":"Layton","year":"2021","journal-title":"Br J Dermatol"},{"issue":"5","key":"ded230020r2","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1111\/bjd.21739","article-title":"A systematic review and network meta-analysis of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris.","volume":"187","author":"Mavranezouli","year":"2022","journal-title":"Br J Dermatol"},{"key":"ded230020r3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadr.2021.100230","article-title":"Isotretinoin and neuropsychiatric side effects: Continued vigilance is needed.","volume":"6","author":"Bremner","year":"2021","journal-title":"J Affect Disord Rep"},{"key":"ded230020r4","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.4579","article-title":"Risk of suicide and psychiatric disorders among isotretinoin users: a meta-analysis.","author":"Tan","journal-title":"JAMA Dermatol"},{"issue":"6","key":"ded230020r5","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.jaad.2016.12.028","article-title":"Isotretinoin treatment for acne and risk of depression: a systematic review and meta-analysis.","volume":"76","author":"Huang","year":"2017","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"ded230020r6","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-021549","article-title":"Use of isotretinoin and risk of depression in patients with acne: a systematic review and meta-analysis.","volume":"9","author":"Li","year":"2019","journal-title":"BMJ Open"},{"issue":"7","key":"ded230020r7","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1111\/jdv.2017.31.issue-7","article-title":"No evidence for increased anxiety in acne patients treated with isotretinoin.","volume":"31","author":"Huang","year":"2017","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"ded230020r8","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/jdv.v34.6","article-title":"Isotretinoin and risk factors for suicide attempt: a population-based comprehensive case series and nested case-control study using 2010-2014 French health insurance data.","volume":"34","author":"Droitcourt","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"ded230020r10","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1111\/bjd.2004.151.issue-6","article-title":"Detection of psychological distress in patients with psoriasis: low consensus between dermatologist and patient.","volume":"151","author":"Richards","year":"2004","journal-title":"Br J Dermatol"},{"issue":"7","key":"ded230020r11","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1111\/ijd.2010.49.issue-7","article-title":"The knowledge, awareness, and practice patterns of dermatologists toward psychocutaneous disorders: results of a survey study.","volume":"49","author":"Jafferany","year":"2010","journal-title":"Int J Dermatol"},{"issue":"2","key":"ded230020r12","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1001\/jamadermatol.2017.5540","article-title":"The PHQ-2 in dermatology-standardized screening for depression and suicidal ideation.","volume":"154","author":"McDonald","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"3","key":"ded230020r13","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/bjd.v182.3","article-title":"Practical screening for depression in dermatology: using technology to improve care.","volume":"182","author":"Gaufin","year":"2020","journal-title":"Br J Dermatol"},{"key":"ded230020r9","unstructured":"Dermatology. Therapeutic Guidelines; 2022. Accessed November 9, 2023. https:\/\/www.tg.org.au"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2812527\/jamadermatology_magin_2023_ed_230020_1705092757.66141.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T17:49:47Z","timestamp":1705513787000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2812527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2023.4577","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1,1]]}}}